Articles From: Hi-Tech Pharmacal Reports Sales of $64.3 Million and EPS of $0.43 for the Third Quarter Ended January 31, 2013 to High Rates of SVR Demonstrated in Phase II Study with Investigational Triple DAA Regimen of Daclatasvir, Asunaprevir and BMS-791325 in Treatment-Naïve Patients with Genotype 1 Chronic Hepatitis C Infection


2013/3/7
Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today reported results for the Company’s fiscal third quarter ended January 31, 2013.
Sign-up for Hi-Tech Pharmacal Reports Sales of $64.3 Million and EPS of $0.43 for the Third Quarter Ended January 31, 2013 investment picks
2013/2/26
Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today announced that it is scheduled to make an investor presentation at the 2013 RBC Capital Markets’ Healthcare Conference Wednesday, February 27, 2013, at 11:00 a.m. Eastern Standard Time.
Sign-up for Hi-Tech Pharmacal to Present at the 2013 RBC Capital Markets’ Healthcare Conference investment picks
2013/5/9
Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today announced that it is scheduled to make an investor presentation at the Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14, 2013, at 10:00 a.m. Pacific Time.
Sign-up for Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2013 Health Care Conference investment picks
2013/4/29
Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today announced that it is scheduled to make an investor presentation at the Needham 12th Annual Healthcare Conference Tuesday, April 29, 2013, at 10:40 a.m. Eastern Time.
Sign-up for Hi-Tech Pharmacal to Present at the Needham 12th Annual Healthcare Conference investment picks
2013/3/4
Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company will release results for its third quarter of Fiscal Year 2013 ended January 31, 2013, prior to the market opening on Thursday March 7, 2013 and will hold a conference call to discuss its financial results at 10 a.m. Eastern Time.
Sign-up for Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 7, 2013 investment picks
2013/5/9
Bally Technologies, Inc. (NYSE: BYI) , a leader in slots, video machines, slot systems and interactive applications announced today that Hialeah Park Casino has selected a wide array of Bally’s award-winning games and systems solutions to engage and excite players at its South Florida property where a new casino will open this summer.
Sign-up for Hialeah Park Casino Selects Bally’s Innovative Games and Systems Solutions; Casino to Utilize iVIEW™ and Elite Bonusing Suite™ to Excite Players in Florida investment picks
2013/3/15
Hibbett Sports, Inc. (NASDAQ/GS: HIBB): Achieves 13th Consecutive Quarter of Comparable Store Sales Increase Fourth Quarter Earnings Per Diluted Share Increases 24% Fiscal Year Earnings Per Diluted Share Increases 27% Issues Fiscal 2014 Guidance Hibbett Sports, Inc. (NASDAQ/GS: HIBB), a sporting goods retailer, today announced results for the fourth quarter and fiscal year ended February 2, 2013.
Sign-up for Hibbett Reports Fourth Quarter and Fiscal 2013 Results investment picks
2013/5/6
Hibbett Sports, Inc. (NASDAQ/GS:HIBB) today announced details for the release of its results for the first quarter ended May 4, 2013.
Sign-up for Hibbett Sports Announces First Quarter Earnings and Conference Call Dates investment picks
2013/2/22
Hibbett Sports, Inc. (NASDAQ/GS: HIBB) today announced details for the release of its results for the fourth quarter and 53-week period ended February 2, 2013.
Sign-up for Hibbett Sports Announces Fourth Quarter Earnings and Conference Call Dates investment picks
2013/5/8
http://media.marketwire.com/attachments/201108/8968_bancorp_building_color.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014819&ProfileId=051205&sourceType=1 NEW ORLEANS, LA --
Sign-up for Hibernia Bancorp, Inc. Reports Operating Results for the Quarter Ended March 31, 2013 investment picks
2013/3/11
HickoryTech Corporation (NASDAQ: HTCO ) today announced that its Board of Directors voted to declare a quarterly dividend of $0.145 per share of HickoryTech common stock.
Sign-up for HickoryTech Declares Quarterly Cash Dividend investment picks
2013/4/30
HickoryTech Corporation (NASDAQ: HTCO) today reported revenue of $48.8 million for the first quarter ending March 31, 2013, an increase of 4 percent year over year.
Sign-up for HickoryTech Reports First Quarter 2013 Results investment picks
2013/3/5
HickoryTech Corporation (NASDAQ: HTCO) today reported fourth quarter revenue of $46.6 million, an increase of 18 percent year over year.
Sign-up for HickoryTech Reports Fourth Quarter 2012 Results investment picks
2013/4/18
HickoryTech Corporation (NASDAQ: HTCO ), a leading communications solution provider, will release its first quarter 2013 results on Tuesday, April 30 after the market closes.
Sign-up for HickoryTech to Report First Quarter 2013 Results on April 30 investment picks
2013/2/13
HickoryTech Corporation (NASDAQ: HTCO ), a leading communications solution provider, will release its fourth quarter 2012 results on Tuesday, March 5 after the market closes.
Sign-up for HickoryTech to Report Fourth Quarter 2012 Results on March 5 investment picks
2013/2/1
High Arctic Announces 2013 Capital Budget and Financial Update Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Sign-up for High Arctic Announces 2013 Capital Budget and Financial Update investment picks
2013/4/19
High Arctic Declares Monthly Dividend Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Sign-up for High Arctic Declares Monthly Dividend investment picks
2013/2/19
High Arctic Declares Monthly Dividend Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Sign-up for High Arctic Declares Monthly Dividend investment picks
2013/3/19
High Arctic Increases Monthly Dividend Canada NewsWire / NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Sign-up for High Arctic Increases Monthly Dividend investment picks
2013/3/13
High Arctic Reports $39.6 Million in Adjusted EBITDA for 2012 Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Sign-up for High Arctic Reports $39.6 Million in Adjusted EBITDA for 2012 investment picks
2013/4/9
http://media.marketwire.com/attachments/200912/208_IndustrialInforesized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1005048&ProfileId=051205&sourceType=1 SUGARLAND, TX --
Sign-up for High Commodity Prices Drive Colorado Gold and Silver Mining Revival, an Industrial Info News Alert investment picks
2013/4/2
Brigus Gold Corp.
Sign-up for High Grade Drilling Results Returned on the 147 and Contact Zones at Grey Fox investment picks
2013/3/18
Brigus Gold Corp.
Sign-up for High Grade Drilling Results to Expand the Resource at Grey Fox investment picks
2013/3/9
High Liner Foods, Inc., the leading value-added seafood supplier in North America, and the Wild Salmon Center today announced the launch of a global Wild Salmon Fishery Improvement Project (FIP) with the goal of increasing volumes of third-party certified sustainable wild capture salmon to 75% of total Pan Pacific production.
Sign-up for High Liner Foods and Wild Salmon Center launch Global “Wild Salmon Fisheries Improvement Project” investment picks
2013/5/8
High Liner Foods Announces Election of Directors Canada NewsWire   About High Liner Foods Incorporated High Liner Foods Incorporated is the leading North American processor and marketer of prepared, value-added frozen seafood.
Sign-up for High Liner Foods Announces Election of Directors investment picks
2013/2/7
High Liner Foods (USA) Inc., the leading value-added seafood supplier in North America, today introduced Battercrisp® Sauce & Serve Shrimp, a new line of sauced shrimp under its FPI® brand that delivers a crunchy, savory taste when paired with many popular sauces and dips.
Sign-up for High Liner Foods Introduces FPI® Battercrisp® Shrimp investment picks
2013/2/20
High Liner Foods Reports 62.5% Improvement in Adjusted EBITDA in 2012 and Announces 36% Dividend Increase Canada NewsWire - First full year of Icelandic USA very accretive to sales, Adjusted EBITDA and Adjusted Net Income - LUNENBURG, NS, Feb.
Sign-up for High Liner Foods Reports 62.5% Improvement in Adjusted EBITDA in 2012 and Announces 36% Dividend Increase investment picks
2013/5/7
High Liner Foods Reports First Quarter 2013 Operating Results Canada NewsWire - Increases Quarterly Dividend by 20% to $0.18 per Share - LUNENBURG, NS, May 7, 2013 /CNW/ - High Liner Foods Incorporated (TSX: HLF) ("High Liner" or "the Company"), the leading North American value-added frozen seafood company, today reported financial results for the thirteen-week period ended March 30 , 2013.
Sign-up for High Liner Foods Reports First Quarter 2013 Operating Results investment picks
2013/4/29
High Liner Foods to Host Conference Call on Wednesday, May 8, 2013 at 10:30 A.M. (ET) Canada NewsWire - Company to report first quarter 2013 results on Tuesday, May 7, 2013 - LUNENBURG, NS, April 29, 2013 /CNW/ - High Liner Foods Incorporated (TSX: HLF) today announced that it will host a conference call on Wednesday, May 8, 2013 at 10:30 a.m. ET ( 11:30 a.m. AT) to discuss its first quarter 2013 financial results.
Sign-up for High Liner Foods to Host Conference Call on Wednesday, May 8, 2013 at 10:30 A.M. (ET) investment picks
2013/4/23
High Rates of SVR Demonstrated in Phase II Study with Investigational Triple DAA Regimen of Daclatasvir, Asunaprevir and BMS-791325 in Treatment-Naïve Patients with Genotype 1 Chronic Hepatitis C Infection Canada NewsWire The study results will be presented this week at the International Liver Congress, the 48 th annual meeting of the European Association for the Study of the Liver (EASL), in Amsterdam .
Sign-up for High Rates of SVR Demonstrated in Phase II Study with Investigational Triple DAA Regimen of Daclatasvir, Asunaprevir and BMS-791325 in Treatment-Naïve Patients with Genotype 1 Chronic Hepatitis C Infection investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Hi-Tech Pharmacal Reports Sales of $64.3 Million and EPS of $0.43 for the Third Quarter Ended January 31, 2013 to High Rates of SVR Demonstrated in Phase II Study with Investigational Triple DAA Regimen of Daclatasvir, Asunaprevir and BMS-791325 in Treatment-Naïve Patients with Genotype 1 Chronic Hepatitis C Infection
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity